<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">80148</article-id><article-id pub-id-type="doi">10.7554/eLife.80148</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>PH domain-mediated autoinhibition and oncogenic activation of Akt</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-191388"><name><surname>Bae</surname><given-names>Hwan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5252-252X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191387"><name><surname>Viennet</surname><given-names>Thibault</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5349-0179</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-279382"><name><surname>Park</surname><given-names>Eunyoung</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5618-1267</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-30969"><name><surname>Chu</surname><given-names>Nam</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191389"><name><surname>Salguero</surname><given-names>Antonieta</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-83519"><name><surname>Eck</surname><given-names>Michael J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4247-9403</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-161176"><name><surname>Arthanari</surname><given-names>Haribabu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-21020"><name><surname>Cole</surname><given-names>Philip A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6873-7824</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biological Chemistry and Molecular Pharmacology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Cancer Biology</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Cancer Biology and Genetics</institution>, <institution>The Ohio State University</institution>, <addr-line><named-content content-type="city">Columbus</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Medicine</institution>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-182970"><name><surname>Andreotti</surname><given-names>Amy H</given-names></name><role>Reviewing editor</role><aff><institution>Iowa State University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>eck@crystal.harvard.edu</email> (ME);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>hari_arthanari@hms.harvard.edu</email> (HA);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>pacole@bwh.harvard.edu</email> (PC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>08</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e80148</elocation-id><history><date date-type="received"><day>12</day><month>05</month><year>2022</year></date><date date-type="accepted"><day>09</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Bae et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Bae et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-80148-v1.pdf"/><abstract><p>Akt is a Ser/Thr protein kinase that plays a central role in metabolism and cancer. Regulation of Akt's activity involves an autoinhibitory intramolecular interaction between its pleckstrin homology (PH) domain and its kinase domain that can be relieved by C-tail phosphorylation. PH domain mutant E17K Akt is a well-established oncogene. Previously, we reported that the conformation of autoinhibited Akt may be shifted by small molecule allosteric inhibitors limiting the mechanistic insights from existing X-ray structures that have relied on such compounds (Chu, Viennet, et al, 2020). Here we discover unexpectedly that a single mutation R86A Akt exhibits intensified autoinhibitory features with enhanced PH domain-kinase domain affinity. Structural and biochemical analysis uncovers the importance of a key interaction network involving Arg86, Glu17, and Tyr18 that controls Akt conformation and activity. Our studies also shed light on the molecular basis for E17K Akt activation as an oncogenic driver.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA74305</award-id><principal-award-recipient><name><surname>Cole</surname><given-names>Philip A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R35CA242461</award-id><principal-award-recipient><name><surname>Eck</surname><given-names>Michael J</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>K22CA241105</award-id><principal-award-recipient><name><surname>Chu</surname><given-names>Nam</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Claudia Adams Barr Program</institution></institution-wrap></funding-source><award-id>Grant</award-id><principal-award-recipient><name><surname>Arthanari</surname><given-names>Haribabu</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>EB002026</award-id><principal-award-recipient><name><surname>Arthanari</surname><given-names>Haribabu</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Kwanjeong Education Foundation</institution></institution-wrap></funding-source><award-id>Fellowship</award-id><principal-award-recipient><name><surname>Bae</surname><given-names>Hwan</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM124165</award-id><principal-award-recipient><name><surname>Eck</surname><given-names>Michael J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Philip A Cole, Senior editor, <italic>eLife</italic>Philip Cole has been a paid consultant for Scorpion Therapeutics..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Diffraction data have been deposited in PDB under the accession code: 7MYXSource data are uploaded as Zip files on the eLife website</p></sec><supplementary-material><ext-link xlink:href="elife-80148-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>